http://www.nature.com/nbt/journal/v2...bt0210-117.pdf
The HER2 testing conundrum
Problems in interpreting diagnostic tests for HER2 may be
compromising patient access to effective treatments. As new versions of therapies targeting HER2 work their way through clinical trials, will the situation get even murkier? Malorye Allison investigates.